For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to replicate.

Scientists looking at the antiviral mechanisms of two previously identified human monoclonal antibodies have found they potently inhibit chikungunya virus (CHIKV) at multiple stages of infection.

Researchers use cryo-EM and optical tweezers to investigate how an antiviral interacts with the herpes simplex virus.

During the complex processes of virus replication and transmission, host cells play a crucial role, especially through the formation of biomolecular condensates (BMCs). These membraneless subcellular ...

New approach for anti-RSV compound discovery. The respiratory syncytial virus (RSV) has been identified as a major causative agent of bronchiolitis in children; nevertheless, avai ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works. The discovery sheds light on an important tool for fighting drug-resistant ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Researchers from Eradivir Inc. and affiliated organizations presented the discovery and preclinical evaluation of EV-21, a dual mechanism antiviral immunotherapy for the treatment of influenza ...

One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many phosphate groups attached to it (a process called hyperphosphorylation), it ...

Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia ...